Skip to content

Investigating the effectiveness and brain mechanisms of low-intensity focused transcranial ultrasound therapy combined with standard rehabilitation training for stroke patients.

Investigating the effectiveness and brain mechanisms of low-intensity focused transcranial ultrasound therapy combined with standard rehabilitation training for stroke patients.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096959
Enrollment
Unknown
Registered
2025-02-10
Start date
2025-02-15
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Transcranial ultrasound group:Daily interventions include 10 minutes of low-intensity transcranial ultrasound therapy and 80 minutes of conventional rehabilitation training.
Sham stimulation group:Daily interventions include 10 minutes of sham transcranial ultrasound stimulation and 80 minutes of conventional rehabilitation training

Sponsors

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1: Aged 40 to 75 years (inclusive of boundary values). 2: Patients with a confirmed diagnosis of first-time stroke through CT or MRI imaging, in accordance with the World Health Organization's definition of stroke. 3: Onset of the stroke between 1 and 6 months. 4: Brunnstrom stage III and above, excluding patients with severe disabilities who are unable to complete the training. 5: Montreal Cognitive Assessment (MoCA) score of >=26 points. 6: Voluntarily participating in the study and signing an informed consent form.

Exclusion criteria

Exclusion criteria: 1: Comorbidities affecting functional recovery, such as heart, lung, liver, kidney, and hematological system diseases. 2: Severe consciousness impairment. 3: A history of or concurrent conditions affecting motor function, such as fractures, trauma, or surgical wounds. 4: Presence of cranial defects or intracranial metal implants. 5: Vulnerable populations, including individuals with mental illnesses, cognitive impairments, critically ill patients, and pregnant women.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer motor function assessment ;Gait parameters ;resting motor threshold, RMT;motor evoked potential, MEP;

Secondary

MeasureTime frame
Berg Balance Scale, BBS;Modified Rankin Scale, mRS;stroke impact scaleSIS;

Countries

China

Contacts

Public ContactHao Xiong

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

707462772@qq.com+86 195 5029 4747

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026